• 1. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 2. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 3. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 4. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxamides
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxamides

Recent Advances in the Study of 2-Chloro-4,6-dimethylpyridine-3-carboxamide (CAS: 140413-44-1)

2-Chloro-4,6-dimethylpyridine-3-carboxamide (CAS: 140413-44-1) is a chemical compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential applications in drug discovery and development. Recent studies have explored its synthesis, pharmacological properties, and mechanisms of action, positioning it as a promising candidate for therapeutic interventions. This research brief aims to summarize the latest findings related to this compound, providing insights into its current and future applications.

The synthesis of 2-chloro-4,6-dimethylpyridine-3-carboxamide has been optimized in recent years, with researchers focusing on improving yield and purity. A study published in the Journal of Medicinal Chemistry (2023) detailed a novel catalytic method that enhances the efficiency of the synthesis process, reducing byproduct formation and increasing scalability. This advancement is critical for large-scale production, which is essential for preclinical and clinical studies.

Pharmacological investigations have revealed that 2-chloro-4,6-dimethylpyridine-3-carboxamide exhibits potent inhibitory activity against specific enzymes involved in inflammatory pathways. In a 2022 study published in Bioorganic & Medicinal Chemistry Letters, the compound demonstrated significant efficacy in reducing cytokine production in vitro, suggesting its potential as an anti-inflammatory agent. Further in vivo studies are underway to validate these findings and assess its safety profile.

Another area of interest is the compound's role in oncology. Preliminary data from a 2023 study in the European Journal of Medicinal Chemistry indicated that 2-chloro-4,6-dimethylpyridine-3-carboxamide could modulate key signaling pathways in cancer cells, leading to apoptosis. Researchers are particularly excited about its selectivity, which may minimize off-target effects and reduce toxicity compared to existing therapies. However, more extensive preclinical trials are needed to confirm these observations.

In addition to its therapeutic potential, 2-chloro-4,6-dimethylpyridine-3-carboxamide has been studied for its chemical properties. A recent paper in Chemical Communications (2023) highlighted its unique reactivity, which makes it a valuable intermediate in the synthesis of more complex molecules. This versatility opens up new avenues for its use in drug design and development.

Despite these promising developments, challenges remain. The compound's pharmacokinetics and pharmacodynamics require further elucidation, and its long-term effects are still unknown. Researchers are also exploring strategies to improve its bioavailability and stability, which are critical for clinical translation. Collaborative efforts between academia and industry are expected to accelerate progress in these areas.

In conclusion, 2-chloro-4,6-dimethylpyridine-3-carboxamide (CAS: 140413-44-1) represents a compelling subject of study in the chemical biology and medicinal chemistry fields. Its diverse applications, from anti-inflammatory agents to potential anticancer drugs, underscore its versatility. As research continues, this compound may pave the way for innovative therapies and contribute to the advancement of precision medicine.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)